Avista Pharma Solutions, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersDurham, NC
US patents14
SAM.gov UEIGRKKCA8LJNE4
CAGE code1YBV9
Incorporated inDE
Brands
Analytical Services
Liquid Phase Peptide Synthesis
Drug ProductThis company sells these brands.
- pharmaceutical
- custom development
- generic APIs
- sites
- API process development
- analytical development
- peptide development
- scales
Named on the company’s own website, read JUL 29, 2026
Open positions
Openings read from Avista Pharma Solutions, INC.’s own job board on iCIMS, last checked OCT 23, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Chemical Process TechnicianWaltham, Massachusetts · Drug Substance Manufacturing · posted OCT 22, 2026
- Sr. Scientist II (ARD)Avista Pharma Solutions, INC. · Durham, North Carolina · Analytical Services · posted OCT 21, 2026
- Manager, Analytical ServicesAvista Pharma Solutions, INC. · Durham, North Carolina · Analytical Services · posted OCT 21, 2026
- Co-Op - Chemical Engineering (Process R&D)Waltham, Massachusetts · Engineering · posted OCT 20, 2026
- Sr. Scientist II (ARD)Avista Pharma Solutions, INC. · Durham, North Carolina · Analytical Services · posted OCT 20, 2026
- Network Systems AdministratorHigh Point, North Carolina · Information Technology · posted OCT 20, 2026
- Co-Op - Chemical EngineeringWaltham, Massachusetts · Engineering · posted OCT 20, 2026
- LIMS SpecialistCharles City, Iowa · QC · posted OCT 20, 2026
- Operational Excellence Principal EngineerCharles City, Iowa · Six Sigma · posted OCT 19, 2026
- Scientist - Process R&DWaltham, Massachusetts · Process R&D · posted OCT 19, 2026
59 more on the company’s board
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
14 US patents granted 2016–2022, 3 of them in the five years to SEP 2025.
Pharmaceuticals 9Organic fine chemistry 5
- Synthetic process and intermediatesUS 11,512,088 · granted NOV 29, 2022
- Chemical compoundsUS 11,459,331 · granted OCT 4, 2022
- Single enantiomer antiparasitic compoundsUS 10,807,992 · granted OCT 20, 2020
- Antiparasitic compoundsUS 10,772,331 · granted SEP 15, 2020
- Sulfonamide derivatives as JAK inhibitorsUS 10,744,136 · granted AUG 18, 2020
Newest 5 shown · Granted to Avista Pharma Solutions, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Avista Pharma Solutions, INC. | Durham | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.